Torrent Pharmaceuticals 과거 수익 실적
과거 기준 확인 6/6
Torrent Pharmaceuticals은 연평균 13%의 비율로 수입이 증가해 온 반면, Pharmaceuticals 산업은 수입이 증가했으며, 연간 13.4%였습니다. 매출은 연평균 7.8%의 비율로 증가했습니다. Torrent Pharmaceuticals의 자기자본이익률은 24%이고 순이익률은 16.1%입니다.
주요 정보
13.0%
수익 성장률
12.9%
EPS 성장률
| Pharmaceuticals 산업 성장 | 17.5% |
| 매출 성장률 | 7.8% |
| 자기자본 수익률 | 24.0% |
| 순이익 | 16.1% |
| 최근 수익 업데이트 | 30 Sep 2024 |
최근 과거 실적 업데이트
Recent updates
Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts
Oct 29
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing
Oct 24Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets
Jul 26Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark
Apr 16Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 03Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00
Feb 05Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings
Jan 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly
Nov 14Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jun 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Mar 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 25Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture
Jun 02Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
May 25A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Feb 18Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00
Jan 27Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly
Jan 04Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock
Dec 14A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Nov 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Sep 30Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?
Sep 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 02I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease
Jun 01Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate
May 14Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 23수익 및 비용 분석
수익 및 비용 분석
Torrent Pharmaceuticals 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 30 Sep 24 | 112,238 | 18,024 | 21,076 | 0 |
| 30 Jun 24 | 109,958 | 17,354 | 20,676 | 0 |
| 31 Mar 24 | 107,278 | 16,564 | 20,166 | 0 |
| 31 Dec 23 | 104,742 | 14,942 | 19,662 | 0 |
| 30 Sep 23 | 102,332 | 13,432 | 18,932 | 0 |
| 30 Jun 23 | 98,642 | 12,692 | 17,842 | 0 |
| 31 Mar 23 | 96,202 | 12,452 | 17,052 | 0 |
| 31 Dec 22 | 92,580 | 8,312 | 16,233 | 0 |
| 30 Sep 22 | 88,750 | 7,972 | 15,883 | 0 |
| 30 Jun 22 | 87,210 | 8,012 | 15,833 | 0 |
| 31 Mar 22 | 85,080 | 7,772 | 15,483 | 0 |
| 31 Dec 21 | 83,158 | 12,189 | 15,227 | 0 |
| 30 Sep 21 | 82,028 | 12,669 | 14,977 | 0 |
| 30 Jun 21 | 80,828 | 12,609 | 14,717 | 0 |
| 31 Mar 21 | 80,046 | 12,519 | 14,597 | 0 |
| 31 Dec 20 | 80,143 | 12,417 | 14,350 | 0 |
| 30 Sep 20 | 79,853 | 11,957 | 14,260 | 0 |
| 30 Jun 20 | 79,733 | 11,297 | 14,210 | 0 |
| 31 Mar 20 | 79,393 | 10,247 | 14,421 | 0 |
| 31 Dec 19 | 78,488 | 5,593 | 14,398 | 0 |
| 30 Sep 19 | 79,338 | 5,543 | 14,538 | 0 |
| 30 Jun 19 | 78,228 | 4,893 | 14,388 | 0 |
| 31 Mar 19 | 76,728 | 4,363 | 14,038 | 0 |
| 31 Dec 18 | 75,141 | 8,161 | 13,743 | 0 |
| 30 Sep 18 | 69,891 | 6,281 | 12,783 | 0 |
| 30 Jun 18 | 65,121 | 6,531 | 12,183 | 0 |
| 31 Mar 18 | 59,498 | 6,781 | 11,353 | 0 |
| 31 Dec 17 | 56,727 | 6,556 | 10,674 | 0 |
| 30 Sep 17 | 56,387 | 8,266 | 10,284 | 0 |
| 30 Jun 17 | 56,387 | 8,296 | 10,044 | 0 |
| 31 Mar 17 | 58,157 | 9,336 | 9,934 | 0 |
| 31 Dec 16 | 59,154 | 10,014 | 10,233 | 0 |
| 30 Sep 16 | 60,144 | 10,624 | 9,913 | 0 |
| 30 Jun 16 | 62,744 | 13,644 | 9,393 | 0 |
| 31 Mar 16 | 66,669 | 17,332 | 8,424 | 0 |
| 31 Dec 15 | 63,315 | 16,299 | 18,653 | 0 |
| 30 Sep 15 | 59,605 | 13,139 | 18,583 | 0 |
| 30 Jun 15 | 54,865 | 9,439 | 18,723 | 0 |
| 31 Mar 15 | 46,535 | 7,509 | 8,772 | 0 |
| 31 Dec 14 | 47,247 | 8,649 | 16,510 | 0 |
| 30 Sep 14 | 45,717 | 8,559 | 16,310 | 0 |
| 30 Jun 14 | 43,267 | 7,709 | 15,890 | 0 |
| 31 Mar 14 | 41,847 | 6,639 | 15,770 | 0 |
| 31 Dec 13 | 38,291 | 5,308 | 13,901 | 0 |
양질의 수익: TORNTPHARM 은 높은 수익을 보유하고 있습니다.
이익 마진 증가: TORNTPHARM 의 현재 순이익 이익률 (16.1%) 작년보다 높습니다 (13.1%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: TORNTPHARM 의 수입은 지난 5년 동안 매년 13% 씩 증가했습니다.
성장 가속화: 지난 1년간 TORNTPHARM 의 수익 증가율( 34.2% )은 연간 평균( 13% 초과합니다. ).
수익 대 산업: 지난 1년간 TORNTPHARM 수익 증가율( 34.2% )은 Pharmaceuticals 업계 20.5% 초과했습니다.
자기자본 수익률
높은 ROE: TORNTPHARM 의 자본 수익률( 24% )은 높음으로 간주됩니다.